Compare Ginkgo Bioworks Holdings Inc (DNA) vs Southern Copper Corp (SCCO) Price & Performance

Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day. The technical outlook is bullish based on moving averages, while oscillators are neutral. Fundamentally, the company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with a negative net income margin of -219.6%. Recent news includes a partnership with TuneLab and a $17.5 million ARPA-H subcontract.

The outlook is challenged by persistent losses and negative cash flow, though strategic partnerships offer growth potential. Analyst sentiment is divided evenly between buy, hold, and sell ratings. Key risks include execution on profitability and high cash burn. The stock presents a speculative opportunity dependent on the company's ability to monetize its technology platform.

Southern Copper (SCCO) trades at $198.66, down 0.95% on the day, with a bearish technical signal and mixed analyst sentiment. The company demonstrates strong fundamentals with revenue growth from $13.42B in 2025 to projected $15.8B in 2026, net income margins improving to 35.87%, and robust profitability metrics including 50.07% ROE. Recent earnings beats and a $10.2B Mexican project pipeline support long-term growth prospects, though the stock trades at premium valuations with P/E of 29.81 and P/S of 10.72.

SCCO presents a complex investment case with strong operational performance offset by valuation concerns. The upside potential lies in continued copper demand growth and project execution, while risks include premium valuation compression, commodity price volatility, and mixed Wall Street sentiment with only 10% buy ratings. Current price sits above the $165.60 consensus target, suggesting limited near-term upside despite fundamental strength.